Laboratory Analysis of Ketotifen Fumarate
Zaditen 2mg Novartis contains ketotifen fumarate, an antihistamine compound extensively studied for its dual-action mechanism as both an H1-receptor antagonist and mast cell stabiliser. This pharmaceutical-grade preparation provides researchers with standardised dosing units for investigating histamine-mediated cellular responses and inflammatory cascade modulation. The compound demonstrates unique properties in laboratory models, exhibiting both immediate antihistamine effects and delayed mast cell membrane stabilisation that distinguishes it from conventional antihistamines in research applications.
Research Applications and Mechanisms
Research teams at Stroid UK Shop utilise this compound to examine histamine receptor binding kinetics and cellular degranulation processes. Studies investigate ketotifen’s prophylactic properties against histamine-induced bronchoconstriction in cell culture models, alongside its effects on inflammatory mediator release from basophils and eosinophils. The compound’s ability to cross the blood-brain barrier makes it valuable for neuroinflammation research, while its oral bioavailability characteristics support pharmacokinetic investigations. Laboratory analyses explore its interaction with selective androgen receptor modulators in inflammatory response studies, particularly examining synergistic effects on immune cell modulation. Research teams also investigate potential interactions with peptide compounds in wound healing and tissue repair models. Advanced studies examine ketotifen’s effects on cyclic AMP levels and protein kinase activation pathways in various cell lines.
Specifications and Storage
| Active Compound | Ketotifen Fumarate |
|---|---|
| Strength | 2mg per tablet |
| Manufacturer | Novartis |
| CAS Number | 34580-14-8 |
| Molecular Formula | C₁₉H₁₉NOS·C₄H₄O₄ |
| Storage Conditions | Room temperature, dry environment |
These pharmaceutical tablets from our ketotifen research collection maintain stability under standard laboratory conditions and provide consistent dosing for experimental protocols requiring precise compound delivery.
Research Compliance Statement
Zaditen 2mg Novartis tablets are supplied exclusively for in-vitro research purposes and laboratory analysis only. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate institutional oversight and safety protocols when handling this material for cellular studies and biochemical investigations.
